Cargando…

Fucosylation in Urological Cancers

Fucosylation is an oligosaccharide modification that plays an important role in immune response and malignancy, and specific fucosyltransferases (FUTs) catalyze the three types of fucosylations: core-type, Lewis type, and H type. FUTs regulate cancer proliferation, invasiveness, and resistance to ch...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fujita, Kazutoshi, Hatano, Koji, Hashimoto, Mamoru, Tomiyama, Eisuke, Miyoshi, Eiji, Nonomura, Norio, Uemura, Hirotsugu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8708646/ https://www.ncbi.nlm.nih.gov/pubmed/34948129 http://dx.doi.org/10.3390/ijms222413333

Ejemplares similares

Prognostic significance of serum fucosylated pro-haptoglobin in advanced renal cell carcinoma patients treated with immune checkpoint inhibitors
por: Kato, Taigo, et al.
Publicado: (2023)

Comparison of molecular profiles of upper tract urothelial carcinoma vs. urinary bladder cancer in the era of targeted therapy: a narrative review
por: Tomiyama, Eisuke, et al.
Publicado: (2022)

The Gut-Prostate Axis: A New Perspective of Prostate Cancer Biology through the Gut Microbiome
por: Fujita, Kazutoshi, et al.
Publicado: (2023)

Emerging Relationship between the Gut Microbiome and Prostate Cancer
por: Matsushita, Makoto, et al.
Publicado: (2023)

Application of Anti-Inflammatory Agents in Prostate Cancer
por: Hatano, Koji, et al.
Publicado: (2020)

Decreased fucosylated PSA as a urinary marker for high Gleason score prostate cancer
por: Fujita, Kazutoshi, et al.
Publicado: (2016)

Connecting the Dots Between the Gut–IGF-1–Prostate Axis: A Role of IGF-1 in Prostate Carcinogenesis
por: Matsushita, Makoto, et al.
Publicado: (2022)

The gut microbiota associated with high‐Gleason prostate cancer
por: Matsushita, Makoto, et al.
Publicado: (2021)

Targeted-sequence of normal urothelium and tumor of patients with non-muscle invasive bladder cancer
por: Hayashi, Yujiro, et al.
Publicado: (2022)

Trop-2 in Upper Tract Urothelial Carcinoma
por: Tomiyama, Eisuke, et al.
Publicado: (2022)

Expression of Nectin-4 and PD-L1 in Upper Tract Urothelial Carcinoma
por: Tomiyama, Eisuke, et al.
Publicado: (2020)

Obesity, Inflammation, and Prostate Cancer
por: Fujita, Kazutoshi, et al.
Publicado: (2019)

Mutational Landscape and Environmental Effects in Bladder Cancer
por: Hayashi, Takuji, et al.
Publicado: (2020)

Peripheral T cell receptor repertoire features predict durable responses to anti-PD-1 inhibitor monotherapy in advanced renal cell carcinoma
por: Kato, Taigo, et al.
Publicado: (2021)

Biological distinction between grades 2 and 3 with respect to intravesical recurrence in T1 high-grade bladder tumors: a retrospective study
por: Yamamoto, Akinaru, et al.
Publicado: (2022)

TERT C228T mutation in non‐malignant bladder urothelium is associated with intravesical recurrence for patients with non‐muscle invasive bladder cancer
por: Hayashi, Yujiro, et al.
Publicado: (2020)

MiR-30b-3p and miR-126-3p of urinary extracellular vesicles could be new biomarkers for prostate cancer
por: Matsuzaki, Kyosuke, et al.
Publicado: (2021)

Role of Androgen Receptor in Prostate Cancer: A Review
por: Fujita, Kazutoshi, et al.
Publicado: (2019)

Genomic Profiling of Prostate Cancer: An Updated Review
por: Hatano, Koji, et al.
Publicado: (2022)

Fucosylation Is a Promising Target for Cancer Diagnosis and Therapy
por: Miyoshi, Eiji, et al.
Publicado: (2012)

Systemic Therapies for Metastatic Castration-Resistant Prostate Cancer: An Updated Review
por: Hatano, Koji, et al.
Publicado: (2023)

Comparative Effectiveness of Radiation Versus Radical Cystectomy for Localized Muscle-Invasive Bladder Cancer
por: Yamamoto, Yoshiyuki, et al.
Publicado: (2022)

Novel diagnostic model for bone metastases in renal cell carcinoma patients based on bone scintigraphy analyzed by computer-aided diagnosis software and bone turnover markers
por: Ujike, Takeshi, et al.
Publicado: (2022)

Influence of Diet and Nutrition on Prostate Cancer
por: Matsushita, Makoto, et al.
Publicado: (2020)

Fragmentation of cell‐free DNA is induced by upper‐tract urothelial carcinoma–associated systemic inflammation
por: Nakano, Kosuke, et al.
Publicado: (2020)

Clinical Significance of Hotspot Mutation Analysis of Urinary Cell-Free DNA in Urothelial Bladder Cancer
por: Hayashi, Yujiro, et al.
Publicado: (2020)

EMMPRIN Promotes Angiogenesis, Proliferation, Invasion and Resistance to Sunitinib in Renal Cell Carcinoma, and Its Level Predicts Patient Outcome
por: Sato, Mototaka, et al.
Publicado: (2013)

MicroRNA‐92b‐3p is a prognostic oncomiR that targets TSC1 in clear cell renal cell carcinoma
por: Wang, Cong, et al.
Publicado: (2020)

Main Inflammatory Cells and Potentials of Anti-Inflammatory Agents in Prostate Cancer
por: Hayashi, Takuji, et al.
Publicado: (2019)

Intratumoral and s.c. injection of inactivated hemagglutinating virus of Japan envelope (GEN0101) in metastatic castration‐resistant prostate cancer
por: Fujita, Kazutoshi, et al.
Publicado: (2020)

Proteomic analysis of urinary and tissue‐exudative extracellular vesicles to discover novel bladder cancer biomarkers
por: Tomiyama, Eisuke, et al.
Publicado: (2021)

Results of weekday-on and weekend-off administration schedule of sunitinib therapy for advanced renal cell carcinoma
por: Kawashima, Atsunari, et al.
Publicado: (2018)

Extracellular vesicles in prostate cancer: a narrative review
por: Hatano, Koji, et al.
Publicado: (2021)

Urinary biomarkers of urological malignancies
por: Fujita, Kazutoshi
Publicado: (2021)

Metastatic testicular cancer presenting with liver and kidney dysfunction treated with modified BEP chemotherapy combined with continuous hemodiafiltration and rasburicase
por: Kimakura, Mai, et al.
Publicado: (2016)

Terminal fucosylation of haptoglobin in cancer-derived exosomes during cholangiocarcinoma progression
por: Choi, Hyewon, et al.
Publicado: (2023)

Sarcopenia and Visceral Obesity are Significantly Related to Severe Storage Symptoms in Geriatric Female Patients
por: Hashimoto, Mamoru, et al.
Publicado: (2021)

Sequential therapy with darolutamide in patients with non‐metastatic castration‐resistant prostate cancer resistant to enzalutamide or apalutamide
por: Fujmoto, Saizo, et al.
Publicado: (2022)

Perioperative circulating tumor DNA enables the identification of patients with poor prognosis in upper tract urothelial carcinoma
por: Nakano, Kosuke, et al.
Publicado: (2022)

Personalized Cancer Therapy for Urological Cancers: From Bench to Bedside and Back
por: Uemura, Hirotsugu, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_1m9vd1k0hp400nj89bi9qbpm1j